Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Breckenridge Pharmaceutical has signed an agreement with Oman Pharmaceutical Products Company, a developer, producer and marketer of generic and OTC pharmaceuticals in the GCC and world-wide, to market Neomycin Sulfate tablets.
Subscribe to our email newsletter
As per the terms of the agreement, Neomycin Sulfate tablets will be manufactured by Oman Pharma, and marketed and distributed by Breckenridge on an exclusive basis in the US.
The ANDA has been approved by the US Food and Drug Administration, and the companies began shipping the product at the start of 2011.
Breckenridge Pharma markets over 70 products in a variety of dosage forms including: tablets, capsules, soft gel capsules, liquids, suspensions and powders.